Gmo Benchmark Free Allocation Fund Quote
| GBMBX Fund | USD 26.42 0.03 0.11% |
Performance8 of 100
| Odds Of DistressLess than 19
|
Gmo Benchmark-free is trading at 26.42 as of the 24th of April 2024; that is -0.11% down since the beginning of the trading day. The fund's open price was 26.45. Gmo Benchmark-free has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Gmo Benchmark Free Allocation are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation fund. In addition, the fund may invest in any other GMO fund, whether now existing or created in the future. These underlying GMO Funds may include, among others, Opportunistic Income fund, Emerging Country Debt fund, High Yield fund, and the Alternative funds. More on Gmo Benchmark Free Allocation
Moving together with Gmo Mutual Fund
| 0.82 | GUSTX | Gmo Treasury | PairCorr |
| 0.77 | GEACX | Gmo Trust | PairCorr |
| 0.85 | GEMEX | Gmo Emerging Markets | PairCorr |
| 0.85 | GEMMX | Gmo Emerging Markets | PairCorr |
| 0.85 | GEMNX | Gmo Emerging Markets | PairCorr |
| 0.98 | GWOAX | Gmo Global Developed | PairCorr |
Gmo Mutual Fund Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Gmo Benchmark-free's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Gmo Benchmark-free or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Fund Concentration | GMO Funds, Large Value Funds, World Allocation Funds, World Allocation, GMO, Large Value, World Allocation (View all Sectors) |
| Update Date | 31st of March 2024 |
Gmo Benchmark Free Allocation [GBMBX] is traded in USA and was established 24th of April 2024. Gmo Benchmark-free is listed under GMO category by Fama And French industry classification. The fund is listed under World Allocation category and is part of GMO family. This fund currently has accumulated 12.53 B in assets under management (AUM) with no minimum investment requirementsGmo Benchmark Free is currently producing year-to-date (YTD) return of 0.89% with the current yeild of 0.01%, while the total return for the last 3 years was 3.03%.
Check Gmo Benchmark-free Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Gmo Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Gmo Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Gmo Benchmark Free Allocation Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Gmo Benchmark Free Allocation Mutual Fund Constituents
| GHVIX | Gmo High Yield | Mutual Fund | High Yield Bond |
| GIMFX | Gmo Implementation Fund | Mutual Fund | World Allocation |
| GMDFX | Gmo Emerging Country | Mutual Fund | Emerging Markets Bond |
| GMODX | Gmo Opportunistic Income | Mutual Fund | Nontraditional Bond |
| GMOQX | Gmo Emerging Country | Mutual Fund | Emerging Markets Bond |
| GSMHX | Gmo Sgm Major | Mutual Fund | Macro Trading |
Gmo Benchmark-free Target Price Odds Analysis
Based on a normal probability distribution, the odds of Gmo Benchmark-free jumping above the current price in 90 days from now is about 24.64%. The Gmo Benchmark Free Allocation probability density function shows the probability of Gmo Benchmark-free mutual fund to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Gmo Benchmark-free has a beta of 0.4984. This usually indicates as returns on the market go up, Gmo Benchmark-free average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Gmo Benchmark Free Allocation will be expected to be much smaller as well. Additionally, gmo Benchmark Free Allocation has an alpha of 1.0E-4, implying that it can generate a 9.3E-5 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Gmo Benchmark-free to move above the current price in 90 days from now is about 24.64 (This Gmo Benchmark Free Allocation probability density function shows the probability of Gmo Mutual Fund to fall within a particular range of prices over 90 days) .
Gmo Benchmark-free Top Holders
| RMDFX | Aspiriant Defensive Allocation | Mutual Fund | Multistrategy |
Gmo Benchmark Free Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Gmo Benchmark-free market risk premium is the additional return an investor will receive from holding Gmo Benchmark-free long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Gmo Benchmark-free. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Gmo Benchmark-free's alpha and beta are two of the key measurements used to evaluate Gmo Benchmark-free's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.2958 | |||
| Semi Deviation | 0.2946 | |||
| Standard Deviation | 0.388 | |||
| Variance | 0.1506 |
Gmo Benchmark-free Against Markets
Picking the right benchmark for Gmo Benchmark-free mutual fund is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Gmo Benchmark-free mutual fund price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Gmo Benchmark-free is critical whether you are bullish or bearish towards Gmo Benchmark Free Allocation at a given time. Please also check how Gmo Benchmark-free's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Gmo Benchmark-free without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
How to buy Gmo Mutual Fund?
Before investing in Gmo Benchmark-free, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Gmo Benchmark-free. To buy Gmo Benchmark-free fund, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Gmo Benchmark-free. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Gmo Benchmark-free fund. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Gmo Benchmark Free Allocation fund in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Gmo Benchmark Free Allocation fund, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the fund
It's important to note that investing in stocks, such as Gmo Benchmark Free Allocation, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in fund prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Gmo Benchmark Free Allocation?
The danger of trading Gmo Benchmark Free Allocation is mainly related to its market volatility and Mutual Fund specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Gmo Benchmark-free is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Gmo Benchmark-free. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Gmo Benchmark Free is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gmo Benchmark Free Allocation. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Gmo Benchmark Free information on this page should be used as a complementary analysis to other Gmo Benchmark-free's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.